Paper28960366
Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C.
Mauro E and 15 others. Hepatology, 2018. Cited by 118 papers, by iCite.
Cite this record
ConductScience Library. Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C. Papers, record 28960366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28960366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiviral Agents | Major topic |
| Hepatitis C | Major topic |
| Hypertension, Portal | Major topic |
| Liver Cirrhosis | Major topic |
| Sustained Virologic Response | Major topic |
| Aged | |
| Elasticity Imaging Techniques | |
| Female | |
| Follow-Up Studies | |
| Hepacivirus | |
| Humans | |
| Liver | |
| Liver Transplantation | |
| Male | |
| Middle Aged | |
| Portal Pressure | |
| Recurrence | |
| Survival Rate |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 29222930 | Regression of HCV cirrhosis: Time will tell. | https://conductscience.org/library/papers/29222930 |
Source PubMed
Cited by63
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 118 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42223671 | Reelin level in serum-derived extracellular vesicles predicts regression of M2BPGi-defined liver fibrosis following hepatitis C virus eradication by direct-acting antiviral agents. | J Gastroenterol | 2026 | https://conductscience.org/library/papers/42223671 | PubMed |
| 40824526 | Future research direction of portal hypertension based on Baveno VII. | Chin Med J (Engl) | 2025 | https://conductscience.org/library/papers/40824526 | PubMed |
| 40689145 | Antifibrotic therapies for metabolic dysfunction-associated steatotic liver disease. | JHEP Rep | 2025 | https://conductscience.org/library/papers/40689145 | PubMed |
| 40542160 | Pretreatment serum angiopoietin-2 predicts prognosis and liver functional reserve after successful HCV eradication with sofosbuvir and velpatasvir in patients with HCV-related decompensated cirrhosis. | J Gastroenterol | 2025 | https://conductscience.org/library/papers/40542160 | PubMed |
| 40480954 | Polyacrylamide Hydrogels with Reversibly Photocontrolled Stiffness for 2D Mechanobiology. | ACS Appl Mater Interfaces | 2025 | https://conductscience.org/library/papers/40480954 | PubMed |
| 39494583 | New Scenarios in Liver Transplantation for Hepatocellular Carcinoma. | Liver Int | 2025 | https://conductscience.org/library/papers/39494583 | PubMed |
| 39285193 | Akkermansia muciniphila in the small intestine improves liver fibrosis in a murine liver cirrhosis model. | NPJ Biofilms Microbiomes | 2024 | https://conductscience.org/library/papers/39285193 | PubMed |
| 39202325 | AI Digital Pathology Using qFibrosis Shows Heterogeneity of Fibrosis Regression in Patients with Chronic Hepatitis B and C with Viral Response. | Diagnostics (Basel) | 2024 | https://conductscience.org/library/papers/39202325 | PubMed |
| 39159947 | KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease. | Clin Mol Hepatol | 2024 | https://conductscience.org/library/papers/39159947 | PubMed |
| 38792873 | Non-Invasive Diagnostic Tests for Portal Hypertension in Patients with HBV- and HCV-Related Cirrhosis: A Comprehensive Review. | Medicina (Kaunas) | 2024 | https://conductscience.org/library/papers/38792873 | PubMed |
| 38739200 | MicroRNA-223-3p levels in serum-derived extracellular vesicles predict regression of M2BPGi-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents. | J Gastroenterol | 2024 | https://conductscience.org/library/papers/38739200 | PubMed |
| 38606180 | Gut microbes combined with metabolomics reveal the protective effects of Qijia Rougan decoction against CCl4-induced hepatic fibrosis. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38606180 | PubMed |
| 38605932 | Noninvasive tests for liver fibrosis in 2024: are there different scales for different diseases? | Gastroenterol Rep (Oxf) | 2024 | https://conductscience.org/library/papers/38605932 | PubMed |
| 38203436 | Hepatitis C Virus and the Host: A Mutual Endurance Leaving Indelible Scars in the Host's Immunity. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38203436 | PubMed |
| 37955206 | Hepatocellular carcinoma risk decreases as time accrues following hepatitis C virus eradication. | Aliment Pharmacol Ther | 2024 | https://conductscience.org/library/papers/37955206 | PubMed |
| 37854023 | A Comprehensive Review of Liver Allograft Fibrosis and Steatosis: From Cause to Diagnosis. | Transplant Direct | 2023 | https://conductscience.org/library/papers/37854023 | PubMed |
| 37795065 | Implementing Better Standard Instruments for Detecting Cirrhosis in Hepatitis C Patients. | Cureus | 2023 | https://conductscience.org/library/papers/37795065 | PubMed |
| 37771878 | Compensated liver cirrhosis: Natural course and disease-modifying strategies. | World J Methodol | 2023 | https://conductscience.org/library/papers/37771878 | PubMed |
| 37763276 | Liver Fibrosis Regression and Associated Factors in HCV Patients Treated with Direct-Acting Antiviral Agents. | Life (Basel) | 2023 | https://conductscience.org/library/papers/37763276 | PubMed |
| 37632072 | Non-Invasive Measurement of Hepatic Fibrosis by Transient Elastography: A Narrative Review. | Viruses | 2023 | https://conductscience.org/library/papers/37632072 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28960366
GET https://conductscience.org/api/papers/v1/28960366/cited_by?page=2